Daily Archives: Novembro 12, 2021 | LinksMedicus Free Medical News & Perspectives

Estudo randomizado | BBV152 (vacina indiana COVAXIN) tem uma eficácia geral de 77,8% contra Covid-19 sintomática em adultos.

12 Nov, 2021 | 13:51h

Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial – The Lancet

Comentário convidado: Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19 – The Lancet

Conteúdo relacionado: WHO issues emergency use approval for India’s Covaxin.

Comentário no Twitter

NEW—Interim data from a phase 3 trial of #BBV152, a COVID-19 vaccine developed in India, suggests it is safe and two doses offer 77.8% protection against symptomatic #COVID19. https://t.co/QWtz0AWd1X

— The Lancet (@TheLancet) November 11, 2021

Controle de infecção na UTI: diretrizes de consenso de especialistas para SARS-CoV-2 utilizando o método Delphi.

12 Nov, 2021 | 13:49h

Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method – The Lancet Infectious Diseases

Comentário da autora no Twitter (fio – clique para saber mais)

Honoured to lead this Delphi on Infection Control in ICU for SARS-CoV-2 with global experts https://t.co/39NTHgfyZR @Drnasap @ElieAzoulay5 @jigidivatia @AlhazzaniW @NaomiHammond @criticcaredoc @YaseenarabiYa @Laura_Evans_206 @FlaviaSepsis @AndersPerner @jlvincen @TheLancetInfDis pic.twitter.com/RWw6vXcHb0

— Sheila Myatra (@SheilaMyatra) November 11, 2021

Mortes de crianças e jovens na Inglaterra após infecção por SARS-CoV-2 durante o 1º ano da pandemia – “Ao todo, 99,995% das crianças e jovens com teste positivo para SARS-CoV-2 sobreviveram.”

12 Nov, 2021 | 13:48h

Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year – Nature

Conteúdo relacionado:

[Preprint] Study confirms children’s extremely low risk of death from Covid-19 – “99·995% of children and young people with a positive SARS-CoV-2 test survived”.

Study: Children and young people remain at low risk of COVID-19 mortality

Comentários no Twitter

Just published @NatureMedicine
An in-depth analysis of the 25 children who died from Covid in England during the 1st year of the pandemichttps://t.co/QK3gk1BXy5
Great that 99.995% of children w/ a positive test survived (not what is driving the need for 💉in kids) pic.twitter.com/moXKl8ysmA

— Eric Topol (@EricTopol) November 11, 2021

A clinical review of all pediatric deaths in England from March 2020 to February 2021 attributes 25 deaths to SARS-CoV-2 infection and identifies risk factors to guide interventions, according to a @NatureMedicine article. https://t.co/Bpjhf5sgow pic.twitter.com/v24Zf9CsXK

— Nature Portfolio (@NaturePortfolio) November 11, 2021

Aumento da imunidade às vacinas contra COVID-19 – “Novos estudos destacam os benefícios imunológicos dos reforços da vacina contra COVID-19, mas ainda restam questões sobre como fazer o melhor uso de suprimentos globais limitados.”

12 Nov, 2021 | 13:46h

Boosting immunity to COVID-19 vaccines – Nature Medicine

A pandemia de COVID prejudicou a produtividade de pesquisadores – bem como sua saúde mental – “Pesquisas mostram que mulheres, pais de crianças pequenas e pessoas não brancas são as mais afetadas pelas disrupções causadas pela pandemia e precisam de mais apoio.”

12 Nov, 2021 | 13:44h

The COVID pandemic has harmed researcher productivity – and mental health – Nature

Mapa | O mundo segundo a cobertura vacinal contra Covid.

12 Nov, 2021 | 13:43h

The world according to covid vaccine coverage – The BMJ

Comentário no Twitter

A year since the first covid vaccines were announced, rollouts are under way all over the world—to differing degrees.

This map shows the percentage of national population to have received two doses of covid vaccinehttps://t.co/rIU3qeWXIK @munkeatlooi pic.twitter.com/zZHr1XXBe8

— The BMJ (@bmj_latest) November 11, 2021